S0348: A Phase II Study of 5T4-Modified Vaccinia Ankara (MVA) Vaccine (TROVAX) in Patients With Advanced Breast Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2013
At a glance
- Drugs MVA 5T4 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Jan 2008 Status change from iniated to withdrawn prior to recruitment, from clinicaltrials.gov record.
- 07 Dec 2005 New trial record.